Crestchem Limited (CRSTCHM.BO)
ValueMarkers Composite Index
87% below intrinsic value ($8)
Crestchem Limited (CRSTCHM.BO) — VMCI valuation read
Across 120 indicators, Crestchem Limited (CRSTCHM.BO) lands at VMCI 64/100. The Healthcare sector median is 50, so the 14-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.
No material Form 4 disclosures landed on CRSTCHM.BO in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.
**Investor frame.** On Value, CRSTCHM.BO trades at 23.0x earnings, 28% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of -0.4x leaves covenant headroom for CRSTCHM.BO on the trailing balance sheet.
CRSTCHM.BO rose 2.8% over the trailing 7 days, with a +7.7% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.